InvestorsHub Logo
Followers 25
Posts 2345
Boards Moderated 0
Alias Born 06/20/2020

Re: misiu143 post# 155011

Friday, 03/26/2021 6:50:34 PM

Friday, March 26, 2021 6:50:34 PM

Post# of 233018

I actually cant think of any other study changing 3 times primary endpoint in one study.


Changing the primary endpoint and adding patients is a good sign in adaptive studies because both are only allowed if the DSMC believes the study is showing promise. CytoDyn never changed primary endpoints or increased enrollment. Maybe because they weren't allowed.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News